Fabien Collangettes

Lithosquare redefines strategic mineral exploration by combining foundational AI and deep geology expertise. More deposits, faster discoveries, greater accuracy, lower costs.

We are Iktos. A start-up company specializing in the development of proprietary artificial intelligence technologies and software for ligand-based and structure-based de novo drug design focusing on multi parametric optimization. Our de novo design algorithm is based on deep generative models with reinforcement learning. It designs novel and easy to make compounds, optimized to meet a given multi-objective blueprint, with unprecedented speed, performance, and diversity. Please visit our webpage to know more about our products and offerings https://iktos.ai/products/

Capsule Corp Labs is a pioneering technology solutions provider, empowering businesses to navigate the Web3 space with ease and confidence. As a strategic partner of Ternoa, we leverage its robust blockchain technology to develop and implement innovative digital solutions. Our expertise lies in simplifying the development of NFT-based projects with a comprehensive, turnkey approach that eliminates the need for complex coding or costly audits. We provide end-to-end support, assisting businesses from the ideation phase to the successful launch of their decentralized applications. We serve a wide array of sectors, from gaming and retail to legal and supply chain, offering tailored solutions that drive efficiency, security, and scalability. Capsule Corp Labs is committed to facilitating the evolution of the Ternoa blockchain ecosystem, helping businesses capitalize on the potential of this revolutionary technology to create a more secure, transparent, and decentralized digital future.

Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. No target is undruggable. Our proprietary technologies, the fruit of over 30 years of research, make it possible to develop novel drug candidates and innovative modes of action against targets previously considered too complex.

Providing genomic analysis to everybody. SeqOne is a company focused on developing state-of-the-art genomic analysis tools for clinical applications in the fields of cancer and rare disease. The companys vision is to develop a genomic analysis system that dramatically reduces the cost and resources needed to provide accurate genomic analysis. Our aim is to make genetic testing easier and more accessible in order to accelerate the adoption of personalized medicine. SeqOne’s platform makes it possible to efficiently analyze "high resolution" next generation sequencing (NGS) data, providing a complete list of all genetic variants and prioritizing them in order of relevance. The platform uses a proprietary machine learning-based variant prioritization engine designed to identify variants that are medically relevant to each specific patient. SeqOne bioinformatics (genomic analysis algorithms) are organized by applications, which provide accurate answers to medical questions that influence patient treatment, in both constitutional and somatic pathologies. SeqOne offers applications to analyze a single-patient or an entire family to diagnose hereditary family disorders, detecting complex events such as large structural modifications or transposable elements. In the field of somatic cancer, applications can analyze tumor-only, compare healthy versus tumoral samples, or hematological cancers identifying relevant variants, such as somatic CNV, TMB, MSI, or fusion genes, as well as suggest therapeutic options. The SeqOne platform addresses the operational challenges of performing NGS analysis at scale, including secure data storage, management of process quality, and traceability needed for certification. We adopt a unique approach to process quality control that addresses ongoing process monitoring as well as changes to upstream lab procedures.

Quandela specialises in the production of photon-based quantum computing and cloud solutions, enabling organisations to achieve their quantum transformation.

Elistair is the global leading manufacturer of automated tethered drone systems for persistent surveillance and emergency communications. The companys products are deployed by police forces, public safety departments, private security companies and governments on over 70 countries. Visit our website : www.elistair.com

An all-in-one platform to help developers deploy, host, and manage web applications on enterprise-grade cloud infrastructure. 👨‍💻 Get started on http://www.artifakt.com

Therapixel is a leading french software company specialized in artificial intelligence for medical imaging. Our aim is to develop a digital radiologist achieving the performance of best experts. Our AI is dedicated to breast cancer screening. That algorithm won the Digital Mammography DREAM Challenge, the largest Artificial Intelligence challenge ever organized. In its early years, Therapixel developed images visualization software for surgeons to make image access easier and faster from patient consultation to the operating room thanks to gesture control and intuitive user interfaces.

Themis Bioscience is an international biotech company that successfully develops vaccines against emerging and specialist indications. Exploiting the full potential of our proprietary Themaxyn® platform we are able to identify and rapidly advance vaccine candidates at various stages of development. Based on a well-proven base technology, the Themaxyn® platform offers both, an excellent safety profile and a validated manufacturing process. Themis Bioscience was founded in 2009 by a group of internationally renowned vaccine and biotech executives in Vienna, Austria. In 2014 Themis successfully completed a phase I clinical trial with our Chikungunya vaccine in Austria. Themis continues to head the race for preventing emerging infectious diseases and started a phase II clinical trial with our Chikungunya vaccine in 2016 and a phase I clinical trial with our Zika vaccine in 2017.

As of August 8, 2019, Sentryo was acquired by Cisco Systems. Sentryo is a software vendor providing cybersecurity and situation awareness solutions dedicated to industrial networks and the Internet of Things. Industrial networks are at the core of our daily lives. They operate smart cities, utilities, energy grids, and many key and critical infrastructures that we all depend on. Merged with IT technologies, they are the foundation of the upcoming Internet of Things where many different kind of smart devices will collaborate. Facing many new threats and punitive regulations, stakeholders must react and organize their cyber-defenses. Unfortunately most IT tools and practices are falling short to deliver the type of protection they need. Sentryo is the pioneer in solutions dedicated to managing the cyber risk of M2M networks and industrial control systems. Sentryo’s ICS CyberVision empowers operation engineers as the front line of defense to ensure integrity, continuity and security of their industrial processes. It leverages unique AI algorithms to give them comprehensive visibility on their industrial assets so they can easily identify vulnerabilities, detect anomalies in real time and work with IT to fight cyber-attacks. Sentryo’s ICS CyberVision is used every day by large corporations in the energy, manufacturing and transportation markets. Sentryo is headquartered in France and has a worldwide presence including offices and partners in Europe, North and South America, Middle-East and Asia.

Greenbureau est une startup spécialisée dans la Relation Client. Nous créons des outils agiles pour simplifier lexpérience client. + Supprimer lattente au service client + Améliorer la qualité de service + Réduire les coûts de la Relation Client Nous offrons aux marques des outils déjà testés et approuvés par des centaines de milliers de consommateurs. Nos outils agiles sadaptent sur tous les supports et ne requièrent aucun développement SI, ni changement dorganisation.

Antelop is an Entrust company. Founded in 2014, Antelop is the Digital Card Partner of banks, certified Visa, Mastercard and CB, answering their Digitization challenges. We digitize cards and secure banking apps. Antelop enables banks with all Digital Cards features into their mobile applications through One single SDK (Card/PIN display, push to XPays, Token management, NFC payments, Strong Authentication...). No more complex back-end integrations, go mobile first! Supported by large international partners, our solutions are live with 40 banks in 25+ countries with proven track-record. Write us at contact@antelop.fr to get in touch

Lithosquare redefines strategic mineral exploration by combining foundational AI and deep geology expertise. More deposits, faster discoveries, greater accuracy, lower costs.

We are Iktos. A start-up company specializing in the development of proprietary artificial intelligence technologies and software for ligand-based and structure-based de novo drug design focusing on multi parametric optimization. Our de novo design algorithm is based on deep generative models with reinforcement learning. It designs novel and easy to make compounds, optimized to meet a given multi-objective blueprint, with unprecedented speed, performance, and diversity. Please visit our webpage to know more about our products and offerings https://iktos.ai/products/

OWN est un Pure Player de la cybersécurité qui se donne carte blanche pour repenser la cybersécurité pour qu’elle soit toujours plus pertinente, efficace et accessible. OWN fonde sa maîtrise sur son expertise en Threat Intelligence, sans autres objectifs que d’améliorer son savoir, ses techniques et méthodes pour gagner en efficacité dans la préservation des systèmes et d’apporter à ses clients un accompagnement cyber éclairé et adapté à leurs besoins.

Capsule Corp Labs is a pioneering technology solutions provider, empowering businesses to navigate the Web3 space with ease and confidence. As a strategic partner of Ternoa, we leverage its robust blockchain technology to develop and implement innovative digital solutions. Our expertise lies in simplifying the development of NFT-based projects with a comprehensive, turnkey approach that eliminates the need for complex coding or costly audits. We provide end-to-end support, assisting businesses from the ideation phase to the successful launch of their decentralized applications. We serve a wide array of sectors, from gaming and retail to legal and supply chain, offering tailored solutions that drive efficiency, security, and scalability. Capsule Corp Labs is committed to facilitating the evolution of the Ternoa blockchain ecosystem, helping businesses capitalize on the potential of this revolutionary technology to create a more secure, transparent, and decentralized digital future.

Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. No target is undruggable. Our proprietary technologies, the fruit of over 30 years of research, make it possible to develop novel drug candidates and innovative modes of action against targets previously considered too complex.